January 20, 2022

expert reaction to press release from Valneva about three doses of their COVID-19 vaccine and serum antibody levels measured in the lab

The press release from Valneva suggests their inactivated COVID-19 vaccine candidate was shown to neutralize the Omicron variant of SARS-CoV-2.

Dr Clive Dix, former Chair of the UK Vaccine Taskforce, said:

“This is very encouraging data and adds to the positive Phase 3 data.  Hopefully this vaccine will be approved soon and should become an important vaccine in both this pandemic in countries still behind the curve and as a vaccine for boosting during the winter of 2022/23.”

https://valneva.com/press-release/valnevas-inactivated-covid-19-vaccine-candidate-shown-to-neutralize-omicron-variant/

All our previous output on this subject can be seen at this weblink:

www.sciencemediacentre.org/tag/covid-19

Declared interests

Dr Clive Dix: “No conflicts.”